Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-30 4 B $4.79 $1,473,366 I/I 307,592 153,706 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-30 4 B $4.79 $982,237 I/I 205,060 1,051,213 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2013-10-15 4 OE $4.94 $49,400 D/D 10,000 3,480,000 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $349,900 I/I 67,679 154,803 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $233,270 I/I 45,120 1,078,323 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-06 4 B $5.23 $1,364,575 I/I 260,913 156,212 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-06 4 B $5.23 $909,717 I/I 173,942 1,113,111 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-03-29 4 A $5.26 $199,996 I/I 38,022 16,146,867 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $1,169,587 I/I 222,355 157,413 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $779,727 I/I 148,237 1,142,758 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-11 4 B $5.27 $608,364 I/I 115,439 115,439 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-11-29 4 A $5.35 $1,000,123 I/I 185,079 3,047,141 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-12 4 B $5.42 $308,940 I/I 57,000 172,439 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-28 4 A $5.46 $999,942 I/I 174,954 2,422,517 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-23 4 B $5.51 $157,845 I/I 28,463 1,299,886 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-13 4 B $5.53 $252,859 I/I 45,725 218,164 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-10-31 4 A $5.54 $999,513 I/I 170,697 2,897,598 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-12-07 4 B $5.55 $1,865,910 I/I 336,200 1,182,000 1.5 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-23 4 B $5.58 $4,154,573 I/I 713,232 1,271,423 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-12-31 4 A $5.66 $1,000,640 I/I 175,879 3,188,586 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-16 4 B $5.73 $147,834 I/I 25,800 243,964 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-18 4 B $5.76 $212,124 I/I 36,827 322,791 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-03-19 4 B $5.80 $5,142,570 I/I 886,650 5,064,196 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-20 4 B $5.85 $1,026,675 I/I 175,500 558,191 2.25 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-01-31 4 B $5.86 $34,999,999 I/I 5,972,696 182,200 2.64 %
  271  Records found
  1   2   3   4   5   6  7   8   9   10   11      
  Page 6 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us